Long-acting formulations currently hold the largest GLP-1 Drug Market share at 57% due to their prolonged effects and ability to minimize patient dosing frequency
Limitations of Use: Do not use Saxenda (liraglutide) if: Read the Instructions for Use that comes with Saxenda (liraglutide)
Further, the peptide has also been found to exert antioxidant effects, while inhibiting carcinogenic receptor expression, giving it anti-tumor effects in breast and colorectal cancer [5, 6]
KLOW if your protocol also requires the KPV anti-inflammatory component
In a cerebrospinal fluid (CSF) substudy, participants receiving semaglutide exhibited modest yet statistically significant reductions (in the range of 10% or less) in several key biomarkers associated with Alzheimers disease (AD) pathology and neurodegeneration, including phosphorylated tau181 (p-tau181), phosphorylated tau217 (p-tau217), total tau, and the neuroinflammatory marker YKL-40 levels